Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review

M. Ferrillo, E. Sommadossi, L. Raciti, D. Calafiore, K. Mezian, V. Tarantino, M. Vecchio, UG. Longo, L. Losco, A. de Sire

. 2025 ; 17 (2) : . [pub] 20250214

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009875

Masticatory muscle hypertrophy (MMH) is a rare clinical phenomenon of uncertain etiology, characterized by a soft swelling near the angle of the jaw. This abnormal enlargement of the masseter muscle can alter the facial profile, leading to aesthetic concerns. Moreover, MMH may also have significant functional repercussions, including pain in the masseter region, often associated with temporomandibular disorders, fatigue, and discomfort during mastication. Non-conservative approaches offer an effective and minimally invasive solution by inducing localized muscle relaxation and reducing hypertrophy. Botulinum neurotoxin type A (BoNT/A) represents a therapeutic option for managing MMH, considering that injections can effectively reduce the masseter muscle volume, improving both facial aesthetics and related symptoms. Currently, the standard non-surgical management of MMH is BoNT/A injections, although consensus on the average dosage has not been definitely reached; on the other hand, there are data available in the literature about the injection technique of BoNT/A for lower face contouring. Therefore, the present comprehensive review aimed at exploring in detail the role of BoNT/A in the treatment of masseter muscle hypertrophy, describing its mechanism of action, the administration protocols, the clinical effects, and any side effects.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009875
003      
CZ-PrNML
005      
20250429135226.0
007      
ta
008      
250415s2025 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/toxins17020091 $2 doi
035    __
$a (PubMed)39998108
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Ferrillo, Martina $u Dentistry Unit, Department of Health Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy $1 https://orcid.org/0000000318784694
245    14
$a The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review / $c M. Ferrillo, E. Sommadossi, L. Raciti, D. Calafiore, K. Mezian, V. Tarantino, M. Vecchio, UG. Longo, L. Losco, A. de Sire
520    9_
$a Masticatory muscle hypertrophy (MMH) is a rare clinical phenomenon of uncertain etiology, characterized by a soft swelling near the angle of the jaw. This abnormal enlargement of the masseter muscle can alter the facial profile, leading to aesthetic concerns. Moreover, MMH may also have significant functional repercussions, including pain in the masseter region, often associated with temporomandibular disorders, fatigue, and discomfort during mastication. Non-conservative approaches offer an effective and minimally invasive solution by inducing localized muscle relaxation and reducing hypertrophy. Botulinum neurotoxin type A (BoNT/A) represents a therapeutic option for managing MMH, considering that injections can effectively reduce the masseter muscle volume, improving both facial aesthetics and related symptoms. Currently, the standard non-surgical management of MMH is BoNT/A injections, although consensus on the average dosage has not been definitely reached; on the other hand, there are data available in the literature about the injection technique of BoNT/A for lower face contouring. Therefore, the present comprehensive review aimed at exploring in detail the role of BoNT/A in the treatment of masseter muscle hypertrophy, describing its mechanism of action, the administration protocols, the clinical effects, and any side effects.
650    _2
$a lidé $7 D006801
650    12
$a musculus masseter $x účinky léků $x patologie $x abnormality $7 D008406
650    12
$a botulotoxiny typu A $x terapeutické užití $x aplikace a dávkování $7 D019274
650    _2
$a nervosvalové látky $x terapeutické užití $7 D009465
650    _2
$a hypertrofie $x farmakoterapie $7 D006984
650    _2
$a zvířata $7 D000818
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Sommadossi, Eleonora $u Private Practice, 10121 Turin, Italy
700    1_
$a Raciti, Loredana $u Unità Spinale Unipolare, Azienda Ospedaliera per le Emergenze Cannizzaro, 98102 Catania, Italy $1 https://orcid.org/0000000305642320
700    1_
$a Calafiore, Dario $u Physical Medicine and Rehabilitation Unit, Department of Neurosciences, ASST Carlo Poma, 46100 Mantova, Italy $1 https://orcid.org/0000000192212497
700    1_
$a Mezian, Kamal $u Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800 Prague, Czech Republic
700    1_
$a Tarantino, Valeria $u Private Practice, 90142 Palermo, Italy
700    1_
$a Vecchio, Michele $u Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy $u Rehabilitation Unit, "AOU Policlinico G. Rodolico-San Marco", 95123 Catania, Italy $1 https://orcid.org/0000000152543283
700    1_
$a Longo, Umile Giuseppe $u Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Roma, Italy $u Research Unit of Orthopaedic and Trauma Surgery, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Roma, Italy $1 https://orcid.org/0000000340639821
700    1_
$a Losco, Luigi $u Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Salerno, Italy $1 https://orcid.org/0000000191051839
700    1_
$a de Sire, Alessandro $u Physical Medicine and Rehabilitation, Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy $u Research Center on Musculoskeletal Health, MusculoSkeletalHealth@UMG, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy $u Department of Rehabilitation and Sports Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, 15006 Prague, Czech Republic $1 https://orcid.org/0000000255418346
773    0_
$w MED00177194 $t Toxins $x 2072-6651 $g Roč. 17, č. 2 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39998108 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135222 $b ABA008
999    __
$a ok $b bmc $g 2311328 $s 1246956
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 17 $c 2 $e 20250214 $i 2072-6651 $m Toxins $n Toxins (Basel) $x MED00177194
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace